Publication | Open Access
Phase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours
41
Citations
0
References
2019
Year
OncologyGenitourinary CancerMedicineArginase Inhibitor Incb001158Solid TumoursPathologyImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentPharmacologyRadiation Oncology
No additional data available for this publication yet. Check back later!